Funding/Investor Session

Session Chair & Speaker - WITH Funding(s)

• 

  Karolina Tkaczuk, PhD Eng.

  Senior Director Innovation and Academic Alliance
  AstraZeneca Pharma Poland, Poland

Speaker - Funded(s)

• 

  Adam Stoten, PhD RTTP

  Dr
  Evotec (UK) Ltd, United Kingdom

Speaker - Not Funded(s)

• 

  Jochen Mueller-Ibeler, PhD (he/him/his)

  Head of New Business Development
  Eppendorf, Germany

Presentations:

• 11:30 – 12:00 CET

  Evotec BRIDGEs; pre-seed funding to accelerate academic drug discovery
  

  Adam Stoten, PhD RTTP – Evotec (UK) Ltd
• 12:00 – 12:30 CET

  Fostering innovation and collaboration
  

  Karolina Tkaczuk, PhD Eng. – AstraZeneca Pharma Poland
• 12:30 – 13:00 CET

  Establishing disruptive innovation capabilities – Creating options for future business expansion
  

  Jochen Mueller-Ibeler, PhD (he/him/his) – Eppendorf